Our team has been hard at work parsing out the most important trends and generating meaningful insights across our customer segments for your company’s business needs. Here’s a quick overview of all of the reports and insights we’ve released this summer, which you can dive into here after signing into our client portal.
For further insights and musings on the oncology sector, please also check out our latest articles at https://www.hmpmarketaccessinsights.com/insights. From articles on the Enhancing Oncology Model and IDN pharmacy performance metrics to payer pathways, we are sure to cover a topic that piques your interest!
Easier access to oncology pathway recommendations encourages oncologists’ usage and considerations of these recommendations. Our new 2024-2025 Oncology Clinical Pathways Impact Report reveals the variability in pathway integration and usage.
Cindy ChenAs Oncology pathway programs continue to become more prominent in the marketplace, manufacturers are being challenged to assess how influential a specific pathway is.
Daniel BuchenbergerIn the final part of this 3-part podcast series, HMP Executive Vice President Lee Blansett and special guest John Hennessy—health system, provider and oncology strategist—explore emerging models for success in oncology practice economics.
Lee Blansett